[1]
S. Sharma, A. Chaturvedi, N. Dave, and A. Shah, “Long-term efficacy and safety of RazumabTM (biosimilar ranibizumab) in Indian patients with retinal diseases: results from retrospective REAR RD-2 study”, Int J Clin Trials, vol. 9, no. 4, pp. 255–262, Oct. 2022.